FDA Plays

[GrandeS]

Investment Bank is rating ALRT as Speculative Buy.

Analyst Research Report. Check this out. www.taglichbrothers.com
Scroll down the right side to see the place to click on research report they have done on ALRT. Taglich is covering ALRT. Very impressive research Report. And they rate ALRT as Speculative BUY. Initial target price of $0.50. Very reasonable as a first target level and surely will be updated often with ever increasing target prices. They would update as price increases and as milestones are reached such as the Medicare policy on electronic verification of use prior to reimbursement, etc.

Game On.